Sartorius AG
https://www.sartorius.us
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Sartorius AG
The Long Learning Curve For Artificially Intelligent Drug Manufacturing Begins Now
Drugmakers quickly adopt low-impact AI/ML models in quest to eventually automate manufacturing processes. Already, they are learning a lot about how these models can support their operations. One finding: innovative change management approaches may be required to unlock their full potential.
The Long Learning Curve For Artificially Intelligent Drug Manufacturing Begins Now
Drugmakers quickly adopt low-impact AI/ML models in quest to eventually automate manufacturing processes. Already, they are learning a lot about how these models can support their operations. One finding: innovative change management approaches may be required to unlock their full potential.
Deal Watch: Japan’s JCR Inks Pacts With Sumitomo Dainippon, Alexion
Agreement with Alexion is JCR’s first international deal for its blood-brain barrier drug delivery technology. Sartoris buys PolyPlus from private equity investors.
Deal Watch: Gemini Goes Through Second Re-Invention Via Reverse Merger With Disc Medicine
Less than two year after going public by a SPAC merger, Gemini will reverse merge with hematology-focused Disc. Bristol Myers Squibb and GentiBio will join forces on Treg development for inflammatory bowel disorders.
Company Information
- Industry
- Research, Analytical Equipment & Supplies
- Services
-
Biotechnology
- Drug Discovery Technologies
- Synthesis Technologies, Production Processes
- Other Names / Subsidiaries
-
- Danaher Corporation, Sartorius Stedim Biotech GmbH
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice